Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tancini

Showing results (71-80 of 218) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2P Lissoni, E Tisi, F Brivio, et al.
The International Journal of Biological Markers|July 1, 1989
The pineal gland and breast cancer: serum levels of melatonin in patients with mammary tumors and their relation to clinical characteristicsS Barni, P Lissoni, A Sormani, et al.
European Journal of Cancer|January 1, 1980
Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of MilanA Rossi, G Bonadonna, G Tancini, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
Tumori|January 1, 1996
Characterization of cancer-related disseminated intravascular coagulation in relation to tumor necrosis factor-alpha blood concentrations: possible therapeutic role of pentoxifyllineP Lissoni, A Ardizzoia, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1989
Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasmsP Lissoni, S Barni, G Tancini, et al.
Tumori|September 1, 1974
[Adriamycin as a single agent in various forms of advanced neoplasia of adults and children (author's transl)]G Bonadonna, G Beretta, G Tancini, et al.
The International Journal of Biological Markers|October 1, 1992
Endocrine effects of human recombinant interleukin-3 in cancer patientsP Lissoni, F Rovelli, E Tisi, et al.
The International Journal of Biological Markers|July 1, 1988
Serum levels of melatonin in cancer patients and their relation to body sizesS Barni, P Lissoni, S Crispino, et al.
Pageof 22

Showing results (71-80 of 218) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2P Lissoni, E Tisi, F Brivio, et al.
The International Journal of Biological Markers|July 1, 1989
The pineal gland and breast cancer: serum levels of melatonin in patients with mammary tumors and their relation to clinical characteristicsS Barni, P Lissoni, A Sormani, et al.
European Journal of Cancer|January 1, 1980
Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of MilanA Rossi, G Bonadonna, G Tancini, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
Tumori|January 1, 1996
Characterization of cancer-related disseminated intravascular coagulation in relation to tumor necrosis factor-alpha blood concentrations: possible therapeutic role of pentoxifyllineP Lissoni, A Ardizzoia, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1989
Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasmsP Lissoni, S Barni, G Tancini, et al.
Tumori|September 1, 1974
[Adriamycin as a single agent in various forms of advanced neoplasia of adults and children (author's transl)]G Bonadonna, G Beretta, G Tancini, et al.
The International Journal of Biological Markers|October 1, 1992
Endocrine effects of human recombinant interleukin-3 in cancer patientsP Lissoni, F Rovelli, E Tisi, et al.
The International Journal of Biological Markers|July 1, 1988
Serum levels of melatonin in cancer patients and their relation to body sizesS Barni, P Lissoni, S Crispino, et al.
Pageof 22